Citation Impact
Citing Papers
Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure
2012
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study
2008
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
2007
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy
2002
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
2013
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction
2008
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload
2008
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials
2012
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients
2016
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Cushing's syndrome
2015 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization
1999 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
2001
Impact of QRS Duration on Clinical Event Reduction With Cardiac Resynchronization Therapy
2011
Cardiac imaging after myocardial infarction
2010
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Cardiovascular magnetic resonance: Structure, function, perfusion, and viability
2005
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review
2011
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance
2006
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
BNP-Guided vs Symptom-Guided Heart Failure Therapy
2009
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
2000
The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure
2001
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Third Universal Definition of Myocardial Infarction
2012 Standout
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
2013
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Intermediate Survival and Predictors of Death After Surgical Ventricular Restoration
2001
The role of inflammatory and fibrogenic pathways in heart failure associated with aging
2010
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy
2004
Structural and Functional Remodeling of the Left Atrium
2008
Biomarkers in Heart Failure
2008 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Recommendations for chamber quantification☆
2006 Standout
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease
1981
Prevention and Treatment of Major Blood Loss
2007
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Usefulness of Left Ventricular Conic Index Measured by Real-Time Three-Dimensional Echocardiography to Predict Left Ventricular Remodeling After Acute Myocardial Infarction
2008
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis
2011
N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF)
2004
Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure)
2010
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart Failure
2000
Heart Failure and Death After Myocardial Infarction in the Community
2005
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients
2004
Coronary artery surgery in women compared with men: Analyses of risks and long-term results
1983
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Racial Variation in Cardiac Procedure Use and Survival Following Acute Myocardial Infarction in the Department of Veterans Affairs
1994 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage
2009
Natriuretic Hormones
1995
Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
1996
Chronic Heart Failure in Congenital Heart Disease
2016
Randomized versus historical controls for clinical trials
1982
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
1997
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
2013
Survival Rates With Coronary Artery Disease for Black Women Compared With Black Men
1992
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
2009
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Addition of Angiotensin II Receptor Blockade to Maximal Angiotensin-Converting Enzyme Inhibition Improves Exercise Capacity in Patients With Severe Congestive Heart Failure
1999
Comparison of Surgical and Medical Group Survival in Patients With Left Main Coronary Artery Disease
1995
Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry.
1989
Ischemic Mitral Regurgitation on the Threshold of a Solution
2005
Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease.
1982
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart
2009
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure
2003
Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials
2015
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure
2000
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles
2005
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
2015
Disease Pathways and Novel Therapeutic Targets in Hypertrophic Cardiomyopathy
2011
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.
1994
Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis
2003
Works of Malcolm Arnold being referenced
Prognostic use of echocardiography 1 year after a myocardial infarction
2005
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction
2001
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
2008
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Fifteen-year results of coronary artery bypass for isolated left anterior descending coronary artery disease
1989
Surgical therapy for left main coronary artery disease
1980
Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction
1997
Coronary Artery Bypass in Women: Long-term Survival
1982
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
1994
DESMOPRESSIN AND MYOCARDIAL INFARCTION
1989
Tumor Necrosis Factor-α Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State
2007
Coronary artery bypass surgery for left main coronary artery disease
1976